logo

For the Inventor, By the Inventor

East Windsor, NJ, United States of America

William Ronald Solvibile

This inventor holds 13 USPTO granted patents and 3 published patent applications, primarily in Beta-Secretase Inhibitors. Top assignee: Wyeth. Active years: 2002-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Ronald Solvibile. Retrieved from https://idiyas.com/inventor/william-ronald-solvibile

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 71(Granted Patents)


Company Filing History:

goldMedal13 out of 1,309 
 
Wyeth
 patents

Years Active: 2002-2011

Loading Chart...
Areas of Expertise:
Beta-Secretase
Histamine Antagonists
Adrenergic Receptor Agonists
Heterocyclic Compounds
Amino-Pyridines
Acylguanidines
Phenylimidazolone
Indazol-3-Yl
Sulfonyl Compounds
Aryl Ethers
Modulation
Pharmaceuticals
13 patents (USPTO):Explore Patents
1. 7935719 - N-substituted-azacyclylamines as histamine-3 antagonists (2011-05-03),
2. 7820825 - N-substituted-azacyclylamines as histamine-3 antagonists (2010-10-26),
3. 7732457 - Amino-pyridines as inhibitors of β-secretase (2010-06-08),
4. 7723368 - Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of beta-secretase (2010-05-25),
5. 7705030 - Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulation (2010-04-27),
6. 7459567 - Substituted thienyl and furyl acylguanidines and methods of their use as beta-secretase modulators (2008-12-02),
7. 7417047 - Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulation (2008-08-26),
8. 7378427 - Processes for preparing 6-alkyl-5-arylsulfonyl-dihydrophenanthridines (2008-05-27),
9. 7241791 - Substituted 4-(indazol-3-yl)phenols (2007-07-10),
10. 6605618 - Heterocyclic beta-3 adrenergic receptor agonists (2003-08-12),
11. 6537994 - Heterocyclic &bgr;3 adrenergic receptor agonists (2003-03-25),
12. 6506901 - Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine &bgr;-3 adrenergic receptor agonists (2003-01-14),
13. 6451814 - Heterocyclic &bgr;-3 adrenergic receptor agonists (2002-09-17),

Title: William Ronald Solvibile - Innovative Inventor from East Windsor

Introduction: William Ronald Solvibile is a renowned inventor hailing from East Windsor, NJ. His passion for innovation and problem-solving has led to numerous groundbreaking inventions in various fields.

Latest Patents: William Ronald Solvibile holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced electronics. His most recent patent involves a revolutionary method for harnessing solar energy in urban environments.

Career Highlights: Throughout his career, William Ronald Solvibile has worked with top research institutions and leading companies to bring his inventions to life. His dedication to creating sustainable solutions has earned him recognition in the industry.

Collaborations: William Ronald Solvibile has collaborated with experts in engineering, environmental science, and design to develop cutting-edge technologies. His partnerships have resulted in innovative products that have the potential to shape the future.

Conclusion: William Ronald Solvibile's contributions to the world of innovation are truly remarkable. His inventive spirit and commitment to sustainability continue to inspire others in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…